For people needing prescription drugs, prices are high and supplies low. Monet Wright suggests some reforms.
Author Archives: Fancy Comma, LLC
For better or worse, the US is charting new territory in health policy. What now?
Politics has fractured federal public health during and after COVID. Bipartisan narratives focused on the greater good can restore public trust in U.S. health initiatives.
What’s at stake with “America First” vs. multilateralism in US Climate Policy — and where do we go from here?
Monet Wright examines multilateralism vs. “America First” climate policies and impacts.
Participatory Action Research as a Research-Based Framework for Rapidly-Evolving Public Health Messaging
Participatory action research could improve public trust in science and communication during health crises.
A Science Freelancer’s Wish List of Creative Projects
Sheeva Azma seeks more creative freedom as a science marketer.
A Moment (and Music Playlist) for Science Creatives
Sheeva shares comments and a Spotify playlist celebrating science creatives.
The 1 Not-So-Weird Trick to Lower Healthcare Costs
Disincentivizing preventable patient harm in hospitals would boost the global economy by 0.7% per year.
Former Congressional Staffer Explains Ways to Make Policy More Evidence-Based with Scientist Involvement
Adriana Bankston spent a year working for Rep. Bill Foster in Congress. She says scientists can advance evidence-based policymaking in Congress.
Congress’s Role in Trump 1.0
Sheeva recaps her experience in Trump 1.0.
How to Be a Good Discussion Moderator, Whether at a Conference or at the Dinner Table
A moderator doesn’t just pick their panelists’ brains, but does so in a way that is interesting and enjoyable for all involved.
Fancy Comma, LLC 